Format: PDF
The global market for the supply of respiratory drugs is expected to hit USD 54.2 billion by 2025, rising over the forecast period at a CAGR of 5.6%. Growth in this market is driven primarily by growing preference for the drug delivery pulmonary path, growing technological advances in the form of smart / digital inhalers and rising incidences of respiratory disorders such as COPD, asthma, and cystic fibrosis.
1 Global Pulmonary/ Respiratory Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Pulmonary/ Respiratory Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Pulmonary/ Respiratory Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Pulmonary/ Respiratory Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Pulmonary/ Respiratory Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Pulmonary/ Respiratory Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Pulmonary/ Respiratory Drug Delivery Market – By Type (Market Size – &
million/billion)
8.1 Suspension Aerosol
8.2 Solution Aerosol
8.3 Dry Powder Formulation
9 Global Pulmonary/ Respiratory Drug Delivery Market – By Device Type
9.1 Metered Dose Inhalers (MDI)
9.2 Dry Powder Inhalers (DPI)
9.3 Nebulizers
10 Global Pulmonary/ Respiratory Drug Delivery Market – By Canister Type
10.1 Plain Canister
10.2 Coated Canister
11 Global Pulmonary/ Respiratory Drug Delivery Market – By Application
11.1 Asthma
11.2 COPD
11.3 Cystic Fibrosis
12 Global Pulmonary/ Respiratory Drug Delivery Market – By End User
12.1 Hospitals &Clinics
12.2 Homecare settings
13 Global Pulmonary/ Respiratory Drug Delivery Market – By Geography (Market Size – &
million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Pulmonary/ Respiratory Drug Delivery Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Pulmonary/ Respiratory Drug Delivery Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Teva Pharmaceutical Industries Ltd.
15.3 3M
15.4 Merck & Co., Inc.
15.5 Glaxosmithkline PLC
15.6 Omron Corporation
15.7 Sunovion Pharmaceuticals Inc.
15.8 Cipla Inc.
15.9 Astrazeneca PLC
15.10 Boehringer Ingelheim
15.11 Novartis AG
15.12 Company 11 & more
16 Global Pulmonary/ Respiratory Drug Delivery Market – Appendix
16.1 Sources
16.2 Abbreviations
Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.
Send me Free SampleOr View Our License Options:
$3,850.00 – $5,850.00
Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.
Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.
We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.
We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.
At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.
Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.
Need Customized Report ?Call NowThe global market for the supply of respiratory drugs is expected to hit USD 54.2 billion by 2025, rising over the forecast period at a CAGR of 5.6%. Growth in this market is driven primarily by growing preference for the drug delivery pulmonary path, growing technological advances in the form of smart / digital inhalers and rising incidences of respiratory disorders such as COPD, asthma, and cystic fibrosis.
1 Global Pulmonary/ Respiratory Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Pulmonary/ Respiratory Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Pulmonary/ Respiratory Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Pulmonary/ Respiratory Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Pulmonary/ Respiratory Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Pulmonary/ Respiratory Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Pulmonary/ Respiratory Drug Delivery Market – By Type (Market Size – &
million/billion)
8.1 Suspension Aerosol
8.2 Solution Aerosol
8.3 Dry Powder Formulation
9 Global Pulmonary/ Respiratory Drug Delivery Market – By Device Type
9.1 Metered Dose Inhalers (MDI)
9.2 Dry Powder Inhalers (DPI)
9.3 Nebulizers
10 Global Pulmonary/ Respiratory Drug Delivery Market – By Canister Type
10.1 Plain Canister
10.2 Coated Canister
11 Global Pulmonary/ Respiratory Drug Delivery Market – By Application
11.1 Asthma
11.2 COPD
11.3 Cystic Fibrosis
12 Global Pulmonary/ Respiratory Drug Delivery Market – By End User
12.1 Hospitals &Clinics
12.2 Homecare settings
13 Global Pulmonary/ Respiratory Drug Delivery Market – By Geography (Market Size – &
million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Pulmonary/ Respiratory Drug Delivery Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Pulmonary/ Respiratory Drug Delivery Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Teva Pharmaceutical Industries Ltd.
15.3 3M
15.4 Merck & Co., Inc.
15.5 Glaxosmithkline PLC
15.6 Omron Corporation
15.7 Sunovion Pharmaceuticals Inc.
15.8 Cipla Inc.
15.9 Astrazeneca PLC
15.10 Boehringer Ingelheim
15.11 Novartis AG
15.12 Company 11 & more
16 Global Pulmonary/ Respiratory Drug Delivery Market – Appendix
16.1 Sources
16.2 Abbreviations
Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.
